1. Home
  2. OSS vs FATE Comparison

OSS vs FATE Comparison

Compare OSS & FATE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OSS
  • FATE
  • Stock Information
  • Founded
  • OSS 1998
  • FATE 2007
  • Country
  • OSS United States
  • FATE United States
  • Employees
  • OSS N/A
  • FATE N/A
  • Industry
  • OSS Computer Manufacturing
  • FATE Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • OSS Technology
  • FATE Health Care
  • Exchange
  • OSS Nasdaq
  • FATE Nasdaq
  • Market Cap
  • OSS 106.4M
  • FATE 125.7M
  • IPO Year
  • OSS 2018
  • FATE 2013
  • Fundamental
  • Price
  • OSS $5.74
  • FATE $1.15
  • Analyst Decision
  • OSS
  • FATE Hold
  • Analyst Count
  • OSS 0
  • FATE 7
  • Target Price
  • OSS N/A
  • FATE $3.58
  • AVG Volume (30 Days)
  • OSS 460.5K
  • FATE 1.5M
  • Earning Date
  • OSS 08-07-2025
  • FATE 08-12-2025
  • Dividend Yield
  • OSS N/A
  • FATE N/A
  • EPS Growth
  • OSS N/A
  • FATE N/A
  • EPS
  • OSS N/A
  • FATE N/A
  • Revenue
  • OSS $55,208,915.00
  • FATE $8,470,000.00
  • Revenue This Year
  • OSS $11.62
  • FATE N/A
  • Revenue Next Year
  • OSS $12.81
  • FATE N/A
  • P/E Ratio
  • OSS N/A
  • FATE N/A
  • Revenue Growth
  • OSS 4.65
  • FATE N/A
  • 52 Week Low
  • OSS $1.85
  • FATE $0.66
  • 52 Week High
  • OSS $6.40
  • FATE $4.20
  • Technical
  • Relative Strength Index (RSI)
  • OSS 60.54
  • FATE 53.09
  • Support Level
  • OSS $4.76
  • FATE $1.06
  • Resistance Level
  • OSS $5.76
  • FATE $1.18
  • Average True Range (ATR)
  • OSS 0.44
  • FATE 0.09
  • MACD
  • OSS -0.01
  • FATE 0.02
  • Stochastic Oscillator
  • OSS 95.15
  • FATE 72.73

About OSS One Stop Systems Inc.

One Stop Systems Inc designs, manufactures, and markets specialized rugged high-performance compute ("HPC"), high-speed switch fabrics, and storage systems, which are designed to target edge applications for artificial intelligence ("AI") / machine learning ("ML"), sensor processing, sensor fusion, and autonomy. The company operates in two reportable segments; OSS designs and manufactures high-performance customized computers and flash arrays, in-flight entertainment & connectivity. Bressner operates as a system integrator with standard and custom all-in-one hardware systems and components for many kinds of industrial environments. The company generates the majority of its revenue from the Bressner segment.

About FATE Fate Therapeutics Inc.

Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. It is engaged in the development of programmed cellular immunotherapies for cancer and autoimmune disorders. The company's cell therapy pipeline is comprised of NK- and T-cell immuno-oncology programs, including off-the-shelf engineered product candidates derived from clonal master iPSC lines, and immuno-regulatory programs, including product candidates to prevent life-threatening complications in patients.

Share on Social Networks: